Brief: Charles River Laboratories And Medigen Vaccine Biologics Corp Collaborate To Advance New Vaccine Development Programs Through Next Generation Sequencing
20/08/2026 13:31
BRIEF-Charles River Laboratories And Medigen Vaccine Biologics Corp Collaborate To Advance New Vaccine Development Programs Through Next Generation Sequencing Charles River Laboratories International, Inc. CRL.N:
CHARLES RIVER LABORATORIES AND MEDIGEN VACCINE BIOLOGICS CORP COLLABORATE TO ADVANCE NEW VACCINE DEVELOPMENT PROGRAMS THROUGH NEXT GENERATION SEQUENCING
Source text: ID:nBw41kSPRa
Further company coverage: CRL.N
Recent news on Charles River Laboratories International
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
European life sciences stocks rise on strong sector momentum